![Peptidomimetic inhibitors of human immunodeficiency virus protease (HIV-PR): Design, enzyme binding and selectivity, antiviral efficacy, and cell permeability properties]()
Peptidomimetic inhibitors of human immunodeficiency virus protease (HIV-PR): Design, enzyme binding and selectivity, antiviral efficacy, and cell permeability propertiesT.K. Sawyer; J.F. Fisher; J.B. Hester; C.W. Smith; A.G. Tomasselli; W.G. Tarpley; P.S. Burton; J.O. Hui; T.J. McQuade; R.A. Conradi; V.S. Bradford; L. Liu; J.H. Kinner; J. Tustin; D.L. Alexander; A.W. Harrison; D.E. Emmert; D.J. Staples; L.L. Maggiora; Y.Z. Zhang; R.A. Poorman; B.M. Dunna; C. Rao; P.E. Scarborough; W.T. Lowther; C. Craik; D. DeCamp; J. Moon; W.J. Howe; R.L. Heinrikson · 1993